Skip to main content
Clinical Trials/NCT06321380
NCT06321380
Not yet recruiting
Not Applicable

Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia

University Hospital, Grenoble0 sites120 target enrollmentApril 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
University Hospital, Grenoble
Enrollment
120
Primary Endpoint
Reaction time
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of the present study is to investigate potential cognitive mechanisms contributing to working memory impairment in Alzheimer's disease and vascular dementia. The investigators consider a new hypothesis suggesting that difficulties in mobilizing maintenance strategies of information could explain this working memory deficit. More specifically, the investigators assume that patient groups will have difficulties in employing both refreshing and elaborative strategies during a working memory task (i.e., complex span task), as compared to a control group.

Detailed Description

Working memory is considered as a central hub in human cognition. Good working memory capacities are fundamental for daily life. However, previous research has indicated that patients with Alzheimer's disease or vascular dementia have significant working memory impairment. Currently, there is no consensus on the cognitive mechanisms responsible for this deficit. Prior findings have highlighted that patients with Alzheimer's disease and/or vascular dementia demonstrate specific difficulties in dual-task situations. In this context, the investigators hypothesize that the continuous alternation between maintenance and processing phases involved in working memory could be impaired for these patients. Thus, the aim of the present study is to investigate if patients with Alzheimer's disease and/or vascular dementia can use maintenance strategies of information in working memory, as typically observed in individuals without cognitive impairments. To this end, the investigators propose a short working memory task in which they manipulate the opportunities to use refreshing strategies and elaborative strategies. The investigators expect that patients with Alzheimer's disease, vascular dementia, or mixed dementia will benefit less than healthy older adults from the increased opportunities to employ refreshing and elaboration. These difficulties could account for the impaired working memory performance associated with these diseases. In a second step, the investigators formulate distinctive hypotheses between patient sub-groups: * On the one hand, Alzheimer's disease is characterized by salient impairment of episodic long-term memory. Consequently, the investigators hypothesize that the working memory decline could be related to this deficit in long-term memory. Specifically, patients with Alzheimer's disease would have greater difficulty in implementing elaboration strategies. Thus, these patients' recall performance should benefit less from semantic links between the to-be-remembered items compared to patients with vascular dementia. * On the other hand, vascular dementia is characterized by a significant impairment of executive functioning. Thus, the investigators hypothesize that the working memory decline could be related to difficulties in implementing refreshing strategies (i.e., voluntary control of attention). Thus, the recall performance of these patients should benefit less from increased free time during the task, compared to patients with Alzheimer's disease. * Finally, very few studies have been carried out on patients with mixed dementia (from both Alzheimer's disease and vascular dementia). The investigators assume that the recall performance of these patients will benefit less from elaborative opportunities compared to patients with dementia vascular, and less from refreshing opportunities compared to patients with Alzheimer's disease.

Registry
clinicaltrials.gov
Start Date
April 2024
End Date
October 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Grenoble
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • For patient and control groups: Adults ≥ 65 years of age
  • For patient and control groups: Native French speaker
  • For patient and control groups: Vision for easy reading
  • For patient and control groups: Hearing for easy instruction understanding
  • For patient and control groups: Back span ≥ 3 during the "Digit Span Backward" subtest (WAIS-IV)
  • For patient and control groups: Formulation of the non-opposition to participate in this study
  • For patient group only: Consultation in Grenoble University Hospital (Centre de Gérontologie Sud - Gerontology center) for clinical neuropsychological assessment due to suspected cognitive impairment
  • For patient group only: Diagnosis of Alzheimer's disease, vascular dementia, or mixed dementia (i.e., Alzheimer's disease and vascular dementia)
  • For patient group only: Have undergone a neuropsychological assessment at the day clinic, less than 6 months old.
  • For patient group only: Have obtained a medical opinion stating that there is no contraindication to participate in this study and no concurrent pathology that could impair the patient's cognitive abilities.

Exclusion Criteria

  • For patient and control groups: People under guardianship or deprived of their freedom
  • For patient and control groups: Diagnosis of severe psychiatric disorders
  • For patient and control groups: Suspicion of pathologies related to alcohol dependence
  • For patient and control groups: No French social security coverage
  • For patient and control groups: Refusal to voluntarily participate in this study
  • For patient and control groups: People covered by articles L1121-5 to L1121-8 of the French Public Health Code
  • For patient group only: Suspicion of another neurodegenerative disease, such as fronto-temporal dementia, Parkinson's disease, Lewy body disease.
  • For patient group only: Clinical neuropsychological assessment did not reveal any cognitive impairment.

Outcomes

Primary Outcomes

Reaction time

Time Frame: 30 minutes

Reaction time for each distractor (in ms) in the spatial part of working memory task

Processing performance in the Working memory task

Time Frame: 15 minutes

Percentage of correct response in the spatial part of working memory task

Memory performance in the Working memory task

Time Frame: 15 minutes

Percentage of correct immediate recall, computed with strict serial recall criterion (item identity + correct position) and computed with item recall criterion (item identity only).

Secondary Outcomes

  • Stroop Test - major interference part (errors)(90 secondes)
  • Trail Making Test - Part A (time)(2 minutes)
  • Digit span backward WAIS IV (standard note)(5 minutes)
  • Stroop Test - minor interference part (Time)(30 secondes)
  • Trail Making Test - Part A (errors)(2 minutes)
  • Stroop Test - minor interference part (errors)(30 secondes)
  • Category fluences(5 minutes)
  • Memory evaluation (16-item Free and Cued Recall, or GERIA-12)(40 minutes)
  • Behavior rating inventory of executive function(10 minutes)
  • Digit span forward WAIS IV (standard note)(5 minutes)
  • Stroop Test - denomination part(30 secondes)
  • Mini-Mental State Examination (MMSE)(15 minutes)
  • Digit span backward WAIS IV (digit number)(5 minutes)
  • Stroop Test - major interference part (time)(90 secondes)
  • Trail Making Test - Part B (time)(5 minutes)
  • Digit span forward WAIS IV (digit number)(5 minutes)
  • Activities of Daily Living(5 minutes)
  • Trail Making Test - Part B (errors)(5 minutes)
  • Naming task(40 minutes)
  • Instrumental Activities of Daily Living(5 minutes)

Similar Trials